FI970068A - Menetelmä 2-(1-atsabisyklo/2,2,2/okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens/de/isokinolin-1-onin ja välituotteen valmistamiseksi - Google Patents

Menetelmä 2-(1-atsabisyklo/2,2,2/okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens/de/isokinolin-1-onin ja välituotteen valmistamiseksi Download PDF

Info

Publication number
FI970068A
FI970068A FI970068A FI970068A FI970068A FI 970068 A FI970068 A FI 970068A FI 970068 A FI970068 A FI 970068A FI 970068 A FI970068 A FI 970068A FI 970068 A FI970068 A FI 970068A
Authority
FI
Finland
Prior art keywords
isoquinolin
azabicyclo
tetrahydro
oct
benzene
Prior art date
Application number
FI970068A
Other languages
English (en)
Swedish (sv)
Other versions
FI970068A0 (fi
FI120198B (fi
Inventor
Charles Alois Dvorak
Bruce Andrew Kowalczyk
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23040964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI970068(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI970068A publication Critical patent/FI970068A/fi
Publication of FI970068A0 publication Critical patent/FI970068A0/fi
Application granted granted Critical
Publication of FI120198B publication Critical patent/FI120198B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI970068A 1994-07-08 1997-01-07 Menetelmä 2-(1-atsabisyklo[2.2.2]okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens[de]isokinolin-1-onin ja välituotteen valmistamiseksi FI120198B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/272,715 US5567818A (en) 1994-07-08 1994-07-08 Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein
US27271594 1994-07-08
PCT/EP1995/002556 WO1996001824A1 (en) 1994-07-08 1995-07-01 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product
EP9502556 1995-07-01

Publications (3)

Publication Number Publication Date
FI970068A true FI970068A (fi) 1997-01-07
FI970068A0 FI970068A0 (fi) 1997-01-07
FI120198B FI120198B (fi) 2009-07-31

Family

ID=23040964

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970068A FI120198B (fi) 1994-07-08 1997-01-07 Menetelmä 2-(1-atsabisyklo[2.2.2]okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens[de]isokinolin-1-onin ja välituotteen valmistamiseksi

Country Status (16)

Country Link
US (1) US5567818A (fi)
EP (1) EP0770077B1 (fi)
JP (1) JP2898758B2 (fi)
CN (1) CN1048727C (fi)
AT (1) ATE205845T1 (fi)
AU (1) AU2979995A (fi)
BR (1) BR9508249A (fi)
CL (2) CL2004001244A1 (fi)
CY (1) CY2342B1 (fi)
DE (1) DE69522808T2 (fi)
DK (1) DK0770077T3 (fi)
ES (1) ES2162929T3 (fi)
FI (1) FI120198B (fi)
MX (1) MX9700157A (fi)
PT (1) PT770077E (fi)
WO (1) WO1996001824A1 (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001227739B2 (en) 2000-04-20 2005-09-29 Masonite Corporation Reverse molded panel
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
US8614225B2 (en) * 2006-08-30 2013-12-24 Dr. Reddy's Laboratories Limited Process for the purification of palonosetron or its salt
US20100016593A1 (en) * 2006-10-23 2010-01-21 Pierluigi Rossetto Crystalline forms of palonosetron hydrochloride
WO2008073757A1 (en) * 2006-12-07 2008-06-19 Helsinn Healthcare Sa Crystalline and amorphous forms of palonosetron hydrochloride
WO2008146283A2 (en) * 2007-05-29 2008-12-04 Chemagis Ltd. Novel palonosetron salts and processes for preparation and purification thereof
WO2009010987A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved process for the preparation of pure palonosetron hydrochloride
AR069625A1 (es) * 2007-12-13 2010-02-03 Glenmark Generics Ltd Base libre de palonosetron y procedimiento para su preparacion
WO2009087643A1 (en) * 2008-01-11 2009-07-16 Natco Pharma Limited Novel crystalline forms of palonosetron hydrochloride
WO2009136405A1 (en) * 2008-05-05 2009-11-12 Natco Pharma Limited High purity palonosetron base and its solid state characteristics
WO2010056656A2 (en) * 2008-11-11 2010-05-20 Dr. Reddy's Laboratories Ltd. Preparation of crystalline palonosetron hydrochloride
CN101851233B (zh) * 2009-04-03 2013-03-06 四川滇虹医药开发有限公司 盐酸帕洛诺司琼和其前体化合物及制备
US20120267533A1 (en) 2009-06-30 2012-10-25 Ranbaxy Laboratories Limited Processes for the preparation of form i and form ii of palonosetron hydrochloride
WO2011013095A1 (en) 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Processes for the preparation of palonosetron
JP2014070036A (ja) * 2012-09-28 2014-04-21 Mitsubishi Gas Chemical Co Inc １，８−テトラリンジカルボン酸無水物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007191A (en) * 1975-10-14 1977-02-08 E. R. Squibb & Sons, Inc. 2-(Piperidinyl or tetrahydropyridinyl)-alkyl)-2,3-dihydro-3-hydroxy-1H-benz(DE)isoquinolin-1-ones
JPH0662607B2 (ja) * 1989-11-28 1994-08-17 シンテックス（ユー・エス・エイ） インコーポレイテッド 新規三環式化合物
US5202318A (en) * 1990-05-14 1993-04-13 Syntex (U.S.A.) Inc. Tricyclic compounds acting at serotonin receptor subtypes

Also Published As

Publication number Publication date
CN1152313A (zh) 1997-06-18
US5567818A (en) 1996-10-22
CL2004001244A1 (es) 2005-04-15
CY2342B1 (en) 2004-02-06
JP2898758B2 (ja) 1999-06-02
BR9508249A (pt) 1998-01-06
CL2007001958A1 (es) 2008-02-22
WO1996001824A1 (en) 1996-01-25
DE69522808D1 (de) 2001-10-25
EP0770077B1 (en) 2001-09-19
DK0770077T3 (da) 2002-01-14
JPH09508645A (ja) 1997-09-02
AU2979995A (en) 1996-02-09
PT770077E (pt) 2002-02-28
MX9700157A (es) 1997-04-30
FI970068A0 (fi) 1997-01-07
FI120198B (fi) 2009-07-31
ES2162929T3 (es) 2002-01-16
DE69522808T2 (de) 2002-04-04
ATE205845T1 (de) 2001-10-15
CN1048727C (zh) 2000-01-26
EP0770077A1 (en) 1997-05-02

Similar Documents

Publication Publication Date Title
FI970068A (fi) Menetelmä 2-(1-atsabisyklo/2,2,2/okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens/de/isokinolin-1-onin ja välituotteen valmistamiseksi
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
MA23452A1 (fr) Procede de preparation d'agents antiparasitaires consistant en derives d'avermectines et de milbemycines.
MA23831A1 (fr) Derives de quinazoline, procede pour leur preparation et composition les contenant
FI962599A (fi) Enantioselektiivinen menetelmä kiraalisten triaryylijohdannaisten ja niiden valmistuksessa käytettävien kiraalisten välituotteiden valmistamiseksi
FI971609A0 (fi) Menetelmä 4a,5,9,10,11,12-heksahydro-6H-bentsofuro-(3a,3,2-ef)(2)-bentsatsepiinijohdannaisten valmistamiseksi
FI981709A0 (fi) Menetelmä 5-substituoitujen 2-amino-4-okso-pyrrolo/2,3-d/-pyrimidiinien valmistamiseksi
IE870112L (en) Fused benzazepines and intermediates thereof
NO177096C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner
DE69020172D1 (de) Verfahren zur Herstellung von epsilon-Caprolactam.
BE882420A (fr) Nouveaux derives d'alpha-(3,4-dichlorophenyl)-imidazoline ou pyrimidine-2-methanols utiles notamment comme agents antisecretoires et leur procede de preparation
FR2595352B1 (fr) Derives de l'indole utiles comme medicaments et procede et intermediaires pour leur preparation
FR2603276B1 (fr) Procede de production de glycols et de glycerol par hydrogenolyse d'alditols
IL118769A0 (en) Process for stereoselective preparation of (-)3a,6,6,9a-tetramethyl-perhydronaphtho[2,1-b]furan
MA23081A1 (fr) Procede de preparation de derives d'indolone
DE69625102T2 (de) Verfahren zur Herstellung von 3-Methyltetrahydrofuran
FR2604173B1 (fr) Nouveaux derives de l'indole, leur procede de preparation et leur application comme pesticide
DE3069597D1 (en) 3-substituted bicyclic azetidinone derivatives, process for their preparation, and intermediates as well as their preparation
DK0796256T3 (da) Fremgangsmåde til fremstilling af ranitidin
DE59510416D1 (de) Verfahren zur Herstellung von Chlormethylpyridin Derivaten und Acylaminomethylpyridine als Zwischenprodukte
MA20517A1 (fr) Nouveaux derives de l'aminomethyle-6 furo-(3,4-c)-pyridine ainsi que leur procede de preparation
FR2621586B1 (fr) Nouveaux derives de l'azapirodecane, leur procede de preparation et leur application comme medicaments
AU4300397A (en) Process for the manufacture of (2'-fluorophenyl)-3-halopyridines
EE03447B1 (et) Meetod muskariinset aktiivsust omavate stereokeemiliselt puhaste oksiimide valmistamiseks
NO178890C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrol [2,3-bÅindolketoner

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120198

Country of ref document: FI

MA Patent expired